We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
PERISYL COMBI (Alphapharm Pty Ltd)
Product name
PERISYL COMBI
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
106 (255 working days)
Active ingredients
indapamide hemihydrate; perindopril erbumine
Registration type
New generic medicine
Indication
PERISYL COMBI 4/1.25 (tablet) is indicated for:
- Treatment of hypertension. Treatment should not be initiated with this combination.
PERISYL COMBI 2/0.625 (tablet) is indicated for:
- Treatment of hypertension.